Affiliated to research
I am a PhD student at the Clinical Epidemiology Division and resident physician in rheumatology. In my research I am studying the risk for venous thromboembolism in patients with rheumatoid arthritis.
Patients with rheumatoid arthritis (RA) are at increased risk for venous thromboembolism (VTE), usually divided into deep vein thrombosis and pulmonary embolism. This is of high importance since VTE events are relatively common and potentially lethal conditions. To this date, the reason why RA patients are at higher risk than others is only partially known. There are several known risk factors for VTE such as medical comorbidities, surgery, immobilization and age, and many of these are more common in RA patients. But since inflammation is also known to cause VTE events, how much of the explanation lies within RA disease activity? Do drugs that we use for treating RA alter this risk? Should VTE risk be more thoroughly assessed in RA patients? To address these questions, we use data from the Swedish Rheumatology Quality Register (SRQ) linked to other national registers.
MD, University of Gothenburg, 2013.